Evidence map›Paper›PMID 36978346›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Virulence Characteristics and Molecular Typing of Carbapenem-Resistant ST15

Marianna Horváth, Tamás Kovács, József Kun, Attila Gyenesei, Ivelina Damjanova, Zoltán Tigyi, György Schneider

Open access · goldFull text read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Incidence of carbapenemase-resistant isolates ofNew microbes and new infections · 2026
    Article
  3. mBio · 2026
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Marianna HorváthDepartment of Medical Biology and Central Electron Microscope Laboratory, Medical School, University of Pécs, 7624 Pécs, Hungary.
Tamás KovácsDepartment of Biotechnology, Nanophagetherapy Center, Enviroinvest Corporation, 7632 Pécs, Hungary.
József KunBioinformatics Research Group, Genomics and Bioinformatics Core Facility, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
Attila GyeneseiBioinformatics Research Group, Genomics and Bioinformatics Core Facility, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
Ivelina DamjanovaDivision of Microbiological Reference Laboratories, National Public Health Center, 1097 Budapest, Hungary.
Zoltán TigyiDepartment of Medical Microbiology and Immunology, Medical School, University of Pécs, 7624 Pécs, Hungary.
György SchneiderDepartment of Medical Microbiology and Immunology, Medical School, University of Pécs, 7624 Pécs, Hungary.ORCID 0000-0003-4424-7585
University of Pecs · HUEnviroinvest Environmental and Biotechnological Corp · HUNational Center for Epidemiology · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biofilm formationcarbapenem-resistantclinical isolatesKlebsiella pneumoniaevirulence potentialwhole-genome sequencing

Identifiers

PMID36978346
PMCPMC10044539
OpenAlexW4322628581

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read108
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.